Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1999 | 12-1998 | 09-1998 | 06-1998 | 03-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,900 | 7,510 | 2,430 | 5,140 | 5,530 |
| Depreciation Amortization | 2,870 | 10,530 | 7,970 | 5,250 | 2,620 |
| Other Working Capital | 17,800 | -5,280 | 920 | 22,890 | 11,980 |
| Other Operating Activity | 1,200 | 3,180 | 2,530 | 30 | -140 |
| Operating Cash Flow | $31,770 | $15,940 | $13,850 | $33,310 | $19,990 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,300 | -29,000 | -30,270 | -12,250 | -4,470 |
| Other Investing Activity | -330 | -12,580 | 50 | -7,610 | -3,540 |
| Investing Cash Flow | $-3,630 | $-41,580 | $-30,220 | $-19,860 | $-8,010 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -3,200 | -12,020 | -8,920 | -5,900 | -2,920 |
| Other Financing Activity | -22,490 | 36,260 | 23,520 | -8,370 | -9,060 |
| Financing Cash Flow | $-25,690 | $24,240 | $14,600 | $-14,270 | $-11,980 |
| Beginning Cash Position | 800 | 2,200 | 2,200 | 2,200 | 2,200 |
| End Cash Position | 3,240 | 800 | 430 | 1,370 | 2,180 |
| Net Cash Flow | $2,430 | $-1,390 | $-1,770 | $-820 | $-10 |
| Free Cash Flow | |||||
| Operating Cash Flow | 31,770 | 15,940 | 13,850 | 33,310 | 19,990 |
| Free Cash Flow | 31,770 | 15,940 | 13,850 | 33,310 | 19,990 |